252 related articles for article (PubMed ID: 16995596)
1. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
Su CS; Lan MY; Liu JS; Chang CC; Lai SL; Wu HS; Chen SS; Chang YY
Acta Neurol Taiwan; 2006 Sep; 15(3):170-6. PubMed ID: 16995596
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A in the treatment of sialorrhea.
Benson J; Daugherty KK
Ann Pharmacother; 2007 Jan; 41(1):79-85. PubMed ID: 17190848
[TBL] [Abstract][Full Text] [Related]
4. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
[TBL] [Abstract][Full Text] [Related]
5. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
6. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
[TBL] [Abstract][Full Text] [Related]
8. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
Fuster Torres MA; Berini Aytés L; Gay Escoda C
Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and duration of botulinum toxin treatment for drooling in 131 children.
Scheffer AR; Erasmus C; van Hulst K; van Limbeek J; Jongerius PH; van den Hoogen FJ
Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):873-7. PubMed ID: 20855679
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin B reduces sialorrhea in parkinsonism.
Racette BA; Good L; Sagitto S; Perlmutter JS
Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
Melo A; Rodrigues B; Nóbrega AC
J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
[No Abstract] [Full Text] [Related]
13. Thickened saliva after effective management of drooling with botulinum toxin A.
Erasmus CE; Van Hulst K; Van Den Hoogen FJ; Van Limbeek J; Roeleveld N; Veerman EC; Rotteveel JJ; Jongerius PH
Dev Med Child Neurol; 2010 Jun; 52(6):e114-8. PubMed ID: 20163435
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type-A (Botox-A) injections for treatment of sialorrhoea in adults: a New Zealand study.
Shetty S; Dawes P; Ruske D; Al-qudah M; Lyons B
N Z Med J; 2006 Aug; 119(1240):U2129. PubMed ID: 16924280
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy].
Alataş N; Yazgan P; Oztürk A; San I
Kulak Burun Bogaz Ihtis Derg; 2006; 16(2):49-53. PubMed ID: 16763416
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
Verma A; Steele J
Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands].
Carod Artal FJ
Neurologia; 2003 Jun; 18(5):280-4. PubMed ID: 12768517
[TBL] [Abstract][Full Text] [Related]
18. Successful management of drooling with botulinum toxin A in neurologically disabled children.
Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin for treatment of parkinsonian sialorrhea.
Friedman A; Potulska A
Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
Sriskandan N; Moody A; Howlett DC
Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
